← 전체 보충제 목록

코큐텐 (심장)

CoQ10 (Heart)

📑 PubMed 30편 ❤️ 심혈관

📚 관련 논문 (30편)

1.
Coenzyme Q10 to manage chronic heart failure with a reduced ejection fraction: a systematic review and economic evaluation.
Health technology assessment (Winchester, England) 2022 PMID:35076012

1. Health Technol Assess. 2022 Jan;26(4):1-128. doi: 10.3310/KVOU6959. Coenzyme Q10 to manage chronic heart failure with a reduced ejection fraction: a systematic review and economic evaluation. Claxton L(1), Simmonds M(1), Beresford L(1), Cubbon R(2), Dayer M(3), Gottlieb SS(4), Hartshorne-Evan

2.
Coenzyme Q10 for heart failure.
The Cochrane database of systematic reviews 2021 PMID:35608922

2. Cochrane Database Syst Rev. 2021 Feb 3;(2)(2):CD008684. doi: 10.1002/14651858.CD008684.pub3. Coenzyme Q10 for heart failure. Al Saadi T(1), Assaf Y(2)(3), Farwati M(2)(4), Turkmani K(5)(6), Al-Mouakeh A(7), Shebli B(7), Khoja M(8)(9), Essali A(10), Madmani ME(11). Author information: (1)Depa

3.
The effect of statin treatment on circulating coenzyme Q10 concentrations: an updated meta-analysis of randomized controlled trials.
European journal of medical research 2018 PMID:30414615

3. Eur J Med Res. 2018 Nov 10;23(1):57. doi: 10.1186/s40001-018-0353-6. The effect of statin treatment on circulating coenzyme Q10 concentrations: an updated meta-analysis of randomized controlled trials. Qu H(1)(2), Meng YY(3), Chai H(3)(2), Liang F(3)(2), Zhang JY(2), Gao ZY(4)(5), Shi DZ(6)(7

4.
Effects of Coenzyme Q10 on Statin-Induced Myopathy: An Updated Meta-Analysis of Randomized Controlled Trials.
Journal of the American Heart Association 2018 PMID:30371340

4. J Am Heart Assoc. 2018 Oct 2;7(19):e009835. doi: 10.1161/JAHA.118.009835. Effects of Coenzyme Q10 on Statin-Induced Myopathy: An Updated Meta-Analysis of Randomized Controlled Trials. Qu H(1)(2), Guo M(3), Chai H(4)(2), Wang WT(4)(2), Gao ZY(3)(2), Shi DZ(3)(2). Author information: (1)1 China

5.
Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension.
The Cochrane database of systematic reviews 2016 PMID:26935713

5. Cochrane Database Syst Rev. 2016 Mar 3;3(3):CD007435. doi: 10.1002/14651858.CD007435.pub3. Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension. Ho MJ(1), Li EC, Wright JM. Author information: (1)Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.

6.
Effects of coenzyme Q10 on statin-induced myopathy: a meta-analysis of randomized controlled trials.
Mayo Clinic proceedings 2015 PMID:25440725

6. Mayo Clin Proc. 2015 Jan;90(1):24-34. doi: 10.1016/j.mayocp.2014.08.021. Epub 2014 Nov 14. Effects of coenzyme Q10 on statin-induced myopathy: a meta-analysis of randomized controlled trials. Banach M(1), Serban C(2), Sahebkar A(3), Ursoniu S(4), Rysz J(5), Muntner P(6), Toth PP(7), Jones SR

7.
Coenzyme Q10 for heart failure.
The Cochrane database of systematic reviews 2014 PMID:24049047

7. Cochrane Database Syst Rev. 2014 Jun 2;(6):CD008684. doi: 10.1002/14651858.CD008684.pub2. Coenzyme Q10 for heart failure. Madmani ME(1), Yusuf Solaiman A, Tamr Agha K, Madmani Y, Shahrour Y, Essali A, Kadro W. Author information: (1)Department of internal medicine, Case Western Reserve Unive

8.
Effect of coenzyme Q₁₀ supplementation on heart failure: a meta-analysis.
The American journal of clinical nutrition 2013 PMID:23221577

8. Am J Clin Nutr. 2013 Feb;97(2):268-75. doi: 10.3945/ajcn.112.040741. Epub 2012 Dec 5. Effect of coenzyme Q₁₀ supplementation on heart failure: a meta-analysis. Fotino AD(1), Thompson-Paul AM, Bazzano LA. Author information: (1)Department of Medicine, School of Medicine, Tulane University, New

9.
Treatment for mitochondrial disorders.
The Cochrane database of systematic reviews 2012 PMID:22513923

9. Cochrane Database Syst Rev. 2012 Apr 18;2012(4):CD004426. doi: 10.1002/14651858.CD004426.pub3. Treatment for mitochondrial disorders. Pfeffer G(1), Majamaa K, Turnbull DM, Thorburn D, Chinnery PF. Author information: (1)Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne,

10.
Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension.
The Cochrane database of systematic reviews 2009 PMID:19821418

10. Cochrane Database Syst Rev. 2009 Oct 7;(4):CD007435. doi: 10.1002/14651858.CD007435.pub2. Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension. Ho MJ(1), Bellusci A, Wright JM. Author information: (1)Faculty of Medicine, University of Toronto, Toronto, ON, Canada. Updat

11.
Effect of compound fish oil capsules on microvascular function in hypertensive individuals: a triple-blind, randomized, placebo-controlled pilot trial.
Food & function 2026 PMID:41914515

11. Food Funct. 2026 Apr 27;17(8):3611-3624. doi: 10.1039/d5fo05343a. Effect of compound fish oil capsules on microvascular function in hypertensive individuals: a triple-blind, randomized, placebo-controlled pilot trial. Liu B(1)(2), Wang W(3), Teng A(4), Yu C(4), Liang Y(4), Liu A(4)(5), Wu X(2

12.
MitoQ supplementation does not impact redox responses to acute exercise in skeletal muscle of older individuals.
Redox biology 2025 PMID:41308251

12. Redox Biol. 2025 Dec;88:103927. doi: 10.1016/j.redox.2025.103927. Epub 2025 Nov 14. MitoQ supplementation does not impact redox responses to acute exercise in skeletal muscle of older individuals. Broome SC(1), Whitfield J(2), Janssens K(3), Hawley JA(4). Author information: (1)Center for H

13.
Selenoprotein P increases upon selenium and coenzyme Q(10) supplementation and is associated with telomere length, quality of life and reduced inflammation and mortality.
Free radical biology & medicine 2024 PMID:38960007

13. Free Radic Biol Med. 2024 Sep;222:403-413. doi: 10.1016/j.freeradbiomed.2024.06.027. Epub 2024 Jul 2. Selenoprotein P increases upon selenium and coenzyme Q(10) supplementation and is associated with telomere length, quality of life and reduced inflammation and mortality. Alehagen U(1), Aas

14.
Supplementation with selenium and coenzyme Q(10) in an elderly Swedish population low in selenium - positive effects on thyroid hormones, cardiovascular mortality, and quality of life.
BMC medicine 2024 PMID:38714999

14. BMC Med. 2024 May 7;22(1):191. doi: 10.1186/s12916-024-03411-1. Supplementation with selenium and coenzyme Q(10) in an elderly Swedish population low in selenium - positive effects on thyroid hormones, cardiovascular mortality, and quality of life. Alehagen U(1), Alexander J(2), Aaseth JO(3)

15.
Effect of ubiquinol on electrophysiology during high-altitude acclimatization and de-acclimatization: A substudy of the Shigatse CARdiorespiratory fitness (SCARF) randomized clinical trial.
International journal of cardiology 2024 PMID:38307422

15. Int J Cardiol. 2024 Apr 15;401:131817. doi: 10.1016/j.ijcard.2024.131817. Epub 2024 Feb 1. Effect of ubiquinol on electrophysiology during high-altitude acclimatization and de-acclimatization: A substudy of the Shigatse CARdiorespiratory fitness (SCARF) randomized clinical trial. Liu Z(1),

16.
Coenzyme Q10 mitigates macrophage mediated inflammation in heart following myocardial infarction via the NLRP3/IL1β pathway.
BMC cardiovascular disorders 2024 PMID:38281937

45. BMC Cardiovasc Disord. 2024 Jan 28;24(1):76. doi: 10.1186/s12872-024-03729-x. Coenzyme Q10 mitigates macrophage mediated inflammation in heart following myocardial infarction via the NLRP3/IL1β pathway. Pan W(1), Zhou G(1), Hu M(1), Li G(1), Zhang M(1), Yang H(1), Li K(1), Li J(1), Liu T(1),

17.
Effects of an Intervention with Selenium and Coenzyme Q(10) on Five Selected Age-Related Biomarkers in Elderly Swedes Low in Selenium: Results That Point to an Anti-Ageing Effect-A Sub-Analysis of a Previous Prospective Double-Blind Placebo-Controlled Randomised Clinical Trial.
Cells 2023 PMID:37443807

21. Cells. 2023 Jul 4;12(13):1773. doi: 10.3390/cells12131773. Effects of an Intervention with Selenium and Coenzyme Q(10) on Five Selected Age-Related Biomarkers in Elderly Swedes Low in Selenium: Results That Point to an Anti-Ageing Effect-A Sub-Analysis of a Previous Prospective Double-Blind

18.
Selenium and Coenzyme Q(10) Intervention Prevents Telomere Attrition, with Association to Reduced Cardiovascular Mortality-Sub-Study of a Randomized Clinical Trial.
Nutrients 2022 PMID:36014852

44. Nutrients. 2022 Aug 15;14(16):3346. doi: 10.3390/nu14163346. Selenium and Coenzyme Q(10) Intervention Prevents Telomere Attrition, with Association to Reduced Cardiovascular Mortality-Sub-Study of a Randomized Clinical Trial. Opstad TB(1)(2), Alexander J(3), Aaseth JO(4)(5), Larsson A(6), Se

19.
Effects of Ubiquinol and/or D-ribose in Patients With Heart Failure With Preserved Ejection Fraction.
The American journal of cardiology 2022 PMID:35644694

46. Am J Cardiol. 2022 Aug 1;176:79-88. doi: 10.1016/j.amjcard.2022.04.031. Epub 2022 May 27. Effects of Ubiquinol and/or D-ribose in Patients With Heart Failure With Preserved Ejection Fraction. Pierce JD(1), Shen Q(2), Mahoney DE(2), Rahman F(3), Krueger KJ(2), Diaz FJ(4), Clark L(4), Smith C

20.
Coenzyme Q10 in the Treatment of Heart Failure with Preserved Ejection Fraction: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial.
Drugs in R&D 2022 PMID:34826125

22. Drugs R D. 2022 Mar;22(1):25-33. doi: 10.1007/s40268-021-00372-1. Epub 2021 Nov 26. Coenzyme Q10 in the Treatment of Heart Failure with Preserved Ejection Fraction: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial. Samuel TY(1), Hasin T(1), Gotsman I(2), Weitzman T(1), Ben I

21.
Synergetic EGCG and coenzyme Q10 DSPC liposome nanoparticles protect against myocardial infarction.
Biomaterials science 2023 PMID:37646313

48. Biomater Sci. 2023 Oct 10;11(20):6862-6870. doi: 10.1039/d3bm00857f. Synergetic EGCG and coenzyme Q10 DSPC liposome nanoparticles protect against myocardial infarction. Lei W(1), Yang J(1), Wang J(1), Xiao Z(1), Zhou P(1), Zheng S(1), Zhu P(1). Author information: (1)Department of Cardiovasc

22.
Mitochondrial targeted antioxidants, mitoquinone and SKQ1, not vitamin C, mitigate doxorubicin-induced damage in H9c2 myoblast: pretreatment vs. co-treatment.
BMC pharmacology & toxicology 2021 PMID:34530934

33. BMC Pharmacol Toxicol. 2021 Sep 16;22(1):49. doi: 10.1186/s40360-021-00518-6. Mitochondrial targeted antioxidants, mitoquinone and SKQ1, not vitamin C, mitigate doxorubicin-induced damage in H9c2 myoblast: pretreatment vs. co-treatment. Sacks B(#)(1), Onal H(#)(1), Martorana R(1), Sehgal A(1

23.
Coenzyme Q10 and Heart Failure: A State-of-the-Art Review.
Circulation. Heart failure 2016 PMID:27012265

10. Circ Heart Fail. 2016 Apr;9(4):e002639. doi: 10.1161/CIRCHEARTFAILURE.115.002639. Coenzyme Q10 and Heart Failure: A State-of-the-Art Review. Sharma A(1), Fonarow GC(1), Butler J(1), Ezekowitz JA(1), Felker GM(2). Author information: (1)From the Division of Cardiology, Duke University School

24.
Overcoming Challenges With Statin Therapy.
Journal of the American Heart Association 2016 PMID:26819251

6. J Am Heart Assoc. 2016 Jan 27;5(1):e002497. doi: 10.1161/JAHA.115.002497. Overcoming Challenges With Statin Therapy. Spence JD(1), Dresser GK(2). Author information: (1)Stroke Prevention & Atherosclerosis Research Centre, Robarts Research Institute, Western University, London, Ontario, Canada

25.
A current approach to statin intolerance.
Clinical pharmacology and therapeutics 2014 PMID:24727470

16. Clin Pharmacol Ther. 2014 Jul;96(1):74-80. doi: 10.1038/clpt.2014.84. Epub 2014 Apr 11. A current approach to statin intolerance. Tompkins R(1), Schwartzbard A(2), Gianos E(2), Fisher E(2), Weintraub H(2). Author information: (1)Leon H. Charney Division of Cardiology, NYU Langone Medical Cen

26.
Combined therapeutic benefit of mitochondria-targeted antioxidant, MitoQ10, and angiotensin receptor blocker, losartan, on cardiovascular function.
Journal of hypertension 2014 PMID:24309493

45. J Hypertens. 2014 Mar;32(3):555-64. doi: 10.1097/HJH.0000000000000054. Combined therapeutic benefit of mitochondria-targeted antioxidant, MitoQ10, and angiotensin receptor blocker, losartan, on cardiovascular function. McLachlan J(1), Beattie E, Murphy MP, Koh-Tan CH, Olson E, Beattie W, Domi

27.
Coenzyme Q10--a therapeutic agent.
Medsurg nursing : official journal of the Academy of Medical-Surgical Nurses 2012 PMID:23477030

8. Medsurg Nurs. 2012 Nov-Dec;21(6):367-71. Coenzyme Q10--a therapeutic agent. Lance J(1), McCabe S, Clancy RL, Pierce J. Author information: (1)Naval Medical Center, Portsmouth, VA, USA. Coenzyme Q10 (CoQ10) is critical to production of adenosine triphosphate and is an antioxidant that scaveng

28.
Lack of effect of coenzyme q10 on doxorubicin cytotoxicity in breast cancer cell cultures.
Integrative cancer therapies 2012 PMID:22544232

21. Integr Cancer Ther. 2012 Sep;11(3):243-50. doi: 10.1177/1534735412439749. Epub 2012 Apr 26. Lack of effect of coenzyme q10 on doxorubicin cytotoxicity in breast cancer cell cultures. Greenlee H(#)(1)(2)(3), Shaw J(#)(3), Lau YI(3), Naini A(4), Maurer M(2)(3). Author information: (1)Departme

29.
Mitochondria-targeted drugs synergize with 2-deoxyglucose to trigger breast cancer cell death.
Cancer research 2012 PMID:22431711

49. Cancer Res. 2012 May 15;72(10):2634-44. doi: 10.1158/0008-5472.CAN-11-3928. Epub 2012 Mar 19. Mitochondria-targeted drugs synergize with 2-deoxyglucose to trigger breast cancer cell death. Cheng G(1), Zielonka J, Dranka BP, McAllister D, Mackinnon AC Jr, Joseph J, Kalyanaraman B. Author in

30.
Combined atorvastatin and coenzyme Q10 improve the left ventricular function in isoproterenol-induced heart failure in rat.
European journal of pharmacology 2011 PMID:21570962

17. Eur J Pharmacol. 2011 Sep;666(1-3):135-41. doi: 10.1016/j.ejphar.2011.04.061. Epub 2011 May 9. Combined atorvastatin and coenzyme Q10 improve the left ventricular function in isoproterenol-induced heart failure in rat. Garjani A(1), Andalib S, Biabani S, Soraya H, Doustar Y, Garjani A, Male

⚠️ 면책 고지

이 정보는 일반 교육 목적이며 의료 진단/처방을 대체하지 않습니다.